QURE- Uniqure N.V.
Uniqure N.V. (QURE) has 12 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. QURE is classified in the Biotechnology industry within the Health Care sector.
Insider Ownership
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 877.8K | $24.28M | - | |
| CFO | 238.6K | $6.60M | - | |
| Other | 150.4K | $4.16M | - | |
| Other | 106.5K | $2.95M | - | |
| Dir | 58.0K | $1.60M | - |
Activity
Buys and sells only
Transactions
10 filings · page 5
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 26, 2024 | Kapusta Matthew C64 | CEO, Managing Director | Sell | 27,904 | $6.35 | $177,190.40 | -6.0% | -26.0% | +72.3% | |
| Feb 26, 2024 | Caloz Pierre64 | Chief Operating Officer | Sell | 9,455 | $6.47 | $61,173.85 | -9.9% | -26.0% | +72.3% | |
| Sep 18, 2023 | Dolmetsch Ricardo72 | President, R&D | Sell | 5,841 | $7.46 | $43,573.86 | -3.5% | +8.6% | -23.5% | |
| Jul 10, 2023 | Caloz Pierre64 | Chief Operating Officer | Sell | 15,117 | $11.36 | $171,729.12 | -13.7% | -42.6% | -42.3% | |
| Jun 16, 2023 | Caloz Pierre64 | Chief Operating Officer | Sell | 2,920 | $18.80 | $54,896.00 | -2.6% | -60.6% | -74.9% | |
| Jun 16, 2023 | Klemt Christian59 | Chief Financial Officer | Sell | 1,587 | $18.94 | $30,057.78 | -1.2% | -60.6% | -74.9% | |
| Jun 16, 2023 | Gut Robert69 | Director | Sell | 3,228 | $18.88 | $60,944.64 | -6.3% | -60.6% | -74.9% | |
| Jun 16, 2023 | Kaye Jack53 | Director | Sell | 2,280 | $18.93 | $43,160.40 | -6.3% | -60.6% | -74.9% | |
| Jun 16, 2023 | Meek David D.51 | Director | Sell | 2,290 | $18.85 | $43,166.50 | -9.2% | -60.6% | -74.9% | |
| Jun 16, 2023 | Post Leonard E47 | Director | Sell | 2,291 | $18.83 | $43,139.53 | -11.2% | -60.6% | -74.9% |